Bioactivity-Guided Discovery of Human Carboxylesterase Inhibitors from the Roots of Paeonia lactiflora
Jing-Fang Zhang,Wan-Chao Zhong,Yan-Cheng Li,Yun-Qing Song,Gui-Yang Xia,Gui-Hua Tian,Guang-Bo Ge,Sheng Lin
DOI: https://doi.org/10.1021/acs.jnatprod.0c00464
IF: 5.1
2020-09-21
Journal of Natural Products
Abstract:In a continuing search for potential inhibitors against human carboxylesterases 1A1 and 2A1 (hCES1A1 and hCES2A1), an EtOAc extract of the roots of <i>Paeonia lactiflora</i> showed strong hCES inhibition activity. Bioassay-guided fractionation led to the isolation of 26 terpenoids including 12 new ones (<b>1</b>–<b>5</b>, <b>7</b>–<b>12</b>, and <b>26</b>). Among these, sesquiterpenoids <b>1</b> and <b>6</b>, monoterpenoids <b>10</b>, <b>11</b>, and <b>13</b>–<b>15</b>, and triterpenoids <b>18</b>–<b>20</b>, <b>22</b>, and <b>24</b>–<b>26</b> contributed to the hCES2A1 inhibition, in the IC<sub>50</sub> range of 1.9–14.5 μM, while the pentacyclic triterpenoids <b>18</b>–<b>26</b> were responsible for the potent inhibitory activity against hCES1A1, with IC<sub>50</sub> values less than 5.0 μM. The structures of all the compounds were elucidated using MS and 1D and 2D NMR data, and the absolute configurations of the new compounds were resolved via specific rotation, experimental and calculated ECD spectra, and single-crystal X-ray diffraction analysis. The structure–activity relationship analysis highlighted that the free HO-3 group in the pentacyclic triterpenoids is crucial for their potent inhibitory activity against hCES1A1.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00464?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00464</a>.Table of hCES1A1 and hCES2A1 inhibitory data for subfractions A–D; IC<sub>50</sub> values of <b>1</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>13</b>–<b>15</b>, <b>18</b>–<b>20</b>, <b>22</b>, and <b>24</b>–<b>26</b> on hCES2A1; IC<sub>50</sub> values of <b>18</b>–<b>26</b> on hCES1A1; HRMS, 1D and 2D NMR, UV, and ECD spectra of compounds <b>1</b>–<b>5</b>, <b>7</b>–<b>12</b>, and <b>26</b>; in silico prediction of ECD spectra of compounds <b>1</b>–<b>5</b>, <b>7</b>–<b>12</b>, and <b>26</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00464/suppl_file/np0c00464_si_001.pdf">PDF</a>)X-ray crystallographic data of <b>1</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00464/suppl_file/np0c00464_si_002.cif">CIF</a>)This article has not yet been cited by other publications.
plant sciences,chemistry, medicinal,pharmacology & pharmacy